Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Published:2018-04-05 Issue:7 Volume:131 Page:790-798
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Dou Li-Ping,Li Hong-Hua,Wang Lu,Li Fei,Huang Wen-Rong,Yu Li,Liu Dai-Hong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference43 articles.

1. Lack of clarity in the definition of treatment-related mortality: Pediatric acute leukemia and adult acute promyelocytic leukemia as examples;Ethier;Blood,2011

2. The myth of the second remission of acute leukemia in the adult;Forman;Blood,2013

3. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression;Dou;Oncogene,2012

4. Improving survival in acute myeloid leukemia: Pick the best subjects?;Lazarus;J Clin Oncol,2013

5. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission – A review from the acute leukemia working party of the EBMT;Sengsayadeth;Haematologica,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study;Annals of Hematology;2024-09-07

2. Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial;Trials;2022-06-06

3. Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy;Annals of Hematology;2021-11-23

4. Increased risk of cardio-cerebrovascular disease after hematopoietic cell transplantation in patients with previous history;Chinese Medical Journal;2021-06-04

5. The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease;Frontiers in Cell and Developmental Biology;2021-04-22